Laboratoires Servier
Tracked across 3 events · 21 articles · First seen Apr 10, 2026 · Last active Jul 14, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Laboratoires Servier is acquiring the muscular dystrophy business of Edgewise Therapeutics, which will enhance its position in neuromuscular disorders and support its 2030 ambition in neurology.
Jun 01, 2026 · 6 articles
Business
Impact: Laboratoires Servier is strengthening its commitment to rare neurological diseases and advancing its 2030 ambition by partnering with Foundation to develop innovative treatments.
Jun 10, 2026 · 9 articles
Business
Impact: Commercial product OJEMDA included in acquired portfolio.
Jul 14, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Laboratoires Servier live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard